{"disease":{"id":"hepatitis-b","name":"Hepatitis B","therapeutic_area":"Infectious Disease","data":{"aiSummary":"The treatment landscape for Hepatitis B primarily involves long-term antiviral therapy, with tenofovir and entecavir being the mainstays of treatment. Research is ongoing to develop new therapies, including RNA interference (RNAi) and capsid assembly modulators, which aim to improve treatment outcomes and potentially offer a functional cure. Several agents are in Phase 2 trials, and the pipeline includes immunotherapies and combination therapies to enhance viral suppression and improve patient outcomes. The goal of treatment is to suppress viral replication, prevent liver damage, and reduce the risk of cirrhosis and liver cancer.","drug_count":6,"description":"Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. The virus is transmitted through contact with the blood or other body fluids of an infected person. Chronic HBV infection can lead to cirrhosis, liver failure, and liver cancer. Effective antiviral treatments are available to manage chronic HBV, but a cure remains a challenge.","subtype_count":9},"enrichment_level":2,"last_enriched_at":null,"visit_count":0,"created_at":"2026-03-25T12:16:34.932Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"tenofovir-disoproxil-fumarate","indication_name":"Chronic Hepatitis B","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TENOFOVIR DISOPROXIL FUMARATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":34,"revenue":null,"mechanism":null},{"drug_id":"vaccine-administration","indication_name":"Hepatitis B","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vaccine Support Cp","generic_name":"Vaccine administration","company_name":"Women and Infants Hospital of Rhode Island","drug_phase":"marketed","molecular_target":"unknown","drug_class":"vaccine","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis B","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis A and hepatitis B","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis B (recurrence)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis B (travel)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis B (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis B (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis B (newborn)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis B (infant)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis B (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis B (adult)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis B (booster)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis A (newborn)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Hepatitis A (booster)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pediarix","indication_name":"Protection against diphtheria, tetanus, pertussis (whole-cell), hepatitis B, poliomyelitis (inactivated), and Haemophilus influenzae type b (Hib) disease in infants and children from 6 weeks through 6 years of age.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pediarix","generic_name":"pediarix","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Immune system","drug_class":"vaccine","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"pediarix","indication_name":"Protection against diphtheria, tetanus, pertussis (whole-cell), hepatitis B, poliomyelitis (inactivated), and Haemophilus influenzae type b (Hib) disease in infants and children from 6 weeks through 6 years of age, when used in a 3-dose series.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pediarix","generic_name":"pediarix","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Immune system","drug_class":"vaccine","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"baraclude","indication_name":"Lamivudine-Refractory Chronic Hepatitis B","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Baraclude","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"Capsid protein, Protein P, Protein P","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"entecavir","indication_name":"Lamivudine-Refractory Chronic Hepatitis B","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Baraclude","generic_name":"ENTECAVIR","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"","drug_class":"entecavir","quality_score":70,"revenue":null,"mechanism":"Entecavir works by inhibiting the replication of the hepatitis B virus."},{"drug_id":"bulevirtide","indication_name":"Chronic viral hepatitis B with hepatitis D","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hepcludex","generic_name":"BULEVIRTIDE","company_name":"MYR GmbH","drug_phase":"marketed","molecular_target":"Sodium/bile acid cotransporter","drug_class":"","quality_score":17,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":20,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07126041","title":"Scalable Public Health Empowerment, Research, and Education Sites (SPHERES)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1750000,"lead_sponsor_name":"Oxford University Clinical Research Unit Indonesia","has_results":false},{"nct_id":"NCT03108794","title":"A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B","phase":"","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06596213","title":"Hepatitis Inequalities Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04264312","title":"Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria","phase":"","overall_status":"COMPLETED","enrollment_count":76220,"lead_sponsor_name":"Wu Jiang","has_results":false},{"nct_id":"NCT05102838","title":"Prospective Cohort Study on Prognosis of Patients With Hepatitis B/C","phase":"","overall_status":"UNKNOWN","enrollment_count":60000,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05172453","title":"Mother-to-child Transmission of HBV in China","phase":"","overall_status":"UNKNOWN","enrollment_count":50000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04896255","title":"Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B","phase":"","overall_status":"RECRUITING","enrollment_count":33000,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT04035837","title":"The Clinical Cure Project of Chronic Hepatitis B in China","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05937178","title":"Real-world Study Optimizing Nucleotide-analogues","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT06966908","title":"Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection","phase":"","overall_status":"RECRUITING","enrollment_count":16300,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT07169656","title":"Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"The First Affiliated Hospital of Zhengzhou University","has_results":false},{"nct_id":"NCT04525833","title":"Liver Disease and Other Systemic Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","has_results":false},{"nct_id":"NCT00388674","title":"Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection","phase":"","overall_status":"COMPLETED","enrollment_count":12522,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT02749864","title":"Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP)","phase":"","overall_status":"COMPLETED","enrollment_count":12246,"lead_sponsor_name":"Instituto de Investigación Marqués de Valdecilla","has_results":false},{"nct_id":"NCT01681420","title":"Improving Blood Safety and HIV Testing in Brazil","phase":"NA","overall_status":"COMPLETED","enrollment_count":11900,"lead_sponsor_name":"Vitalant Research Institute","has_results":false},{"nct_id":"NCT04538651","title":"A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in China","phase":"","overall_status":"UNKNOWN","enrollment_count":11453,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04301908","title":"A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Beijing Ditan Hospital","has_results":false},{"nct_id":"NCT04914611","title":"Real World Assessment of People Living With Chronic Hepatitis B in Australia","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Kirby Institute","has_results":false},{"nct_id":"NCT06049602","title":"TDF and Entekavir - Hepatitis B Reactivation","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Viral Hepatitis Society","has_results":false},{"nct_id":"NCT06627608","title":"Treatment Prioritisation and Cost-Effectiveness Analysis for HBV Cure - Real-World Evidence from a Territory-Wide Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT05057065","title":"A Clinical Research on Disease Progression and Intervention of Chronic HepatitisB","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Hong Ren","has_results":false},{"nct_id":"NCT03794791","title":"A Comprehensive HBsAg-positive Patients Centered Screening Strategy","phase":"","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"Hong Ren","has_results":false},{"nct_id":"NCT04724785","title":"Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"The Second Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT04029454","title":"Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule","phase":"NA","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT07537387","title":"A Study on the Pursuit of Sustained Clearance of HBsAg in Chronic Hepatitis B(CHB) Patients With Previous Interferon Treatment Using Pegylated Interferon Alpha","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"xieqing","has_results":false},{"nct_id":"NCT04240678","title":"The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening","phase":"NA","overall_status":"COMPLETED","enrollment_count":8299,"lead_sponsor_name":"University of California, Davis","has_results":true},{"nct_id":"NCT00001971","title":"Evaluation of Patients With Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":8050,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT05094869","title":"Prevention of HCC Using Mobile Phone Applications","phase":"","overall_status":"UNKNOWN","enrollment_count":8000,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT07388979","title":"MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":7500,"lead_sponsor_name":"Gardiens de Vies","has_results":false},{"nct_id":"NCT00782158","title":"Hepatitis B and HIV Co-Infection in Patients in Uganda","phase":"","overall_status":"COMPLETED","enrollment_count":6303,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT07258251","title":"Strengthening Hepatitis B Screening, Linkage to Care and Long-Term Monitoring in Phichit Province, Thailand: A Birth Bohort Approach","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"The Task Force for Global Health","has_results":false},{"nct_id":"NCT06084234","title":"National Liver Cancer Screening Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":5500,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT03870061","title":"Evaluation of an Infant Immunization Encouragement Program in Nigeria","phase":"NA","overall_status":"COMPLETED","enrollment_count":5187,"lead_sponsor_name":"GiveWell","has_results":false},{"nct_id":"NCT04503993","title":"Healthy Planet Hepatitis B","phase":"NA","overall_status":"COMPLETED","enrollment_count":5004,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT05181956","title":"Testing and Epidemiology of Delta Hepatitis","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Asian Pacific Liver Center at Coalition of Inclusive Medicine","has_results":false},{"nct_id":"NCT05182463","title":"Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT07137247","title":"Immune Dynamics in the Natural History of Chronic HBV Infection","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04483518","title":"Epidemiological Survey of Hepatitis D Virus Infection in China","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT05394623","title":"Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT06586983","title":"Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia","phase":"","overall_status":"RECRUITING","enrollment_count":4500,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT04160897","title":"Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Qing XIe","has_results":false},{"nct_id":"NCT03702998","title":"Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population","phase":"","overall_status":"COMPLETED","enrollment_count":3900,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT03415334","title":"Effect of Implementation Of Outreach Behavioral Change Program for HCV Elimination","phase":"NA","overall_status":"COMPLETED","enrollment_count":3575,"lead_sponsor_name":"National Research Centre, Egypt","has_results":false},{"nct_id":"NCT03825458","title":"Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.","phase":"","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03215732","title":"Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal","phase":"","overall_status":"COMPLETED","enrollment_count":3119,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT04366492","title":"HBV/HCV/HIV in Belgian Prisons","phase":"NA","overall_status":"COMPLETED","enrollment_count":3045,"lead_sponsor_name":"Hasselt University","has_results":false},{"nct_id":"NCT04056728","title":"A Phase IV Study to Assess the Safety of EupentaTM Inj","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"LG Chem","has_results":false},{"nct_id":"NCT03642340","title":"A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"IlDong Pharmaceutical Co Ltd","has_results":false},{"nct_id":"NCT03221049","title":"Radiomics for Diagnosing Liver Diseases and Evaluating Progression","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03408730","title":"Lot-to-lot Consistency of Sci-B-Vac™ in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2838,"lead_sponsor_name":"VBI Vaccines Inc.","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}